Kidney Cancer Treatment Information
Kidney cancer (or renal cell cancer) is a broad category of cancers in which malignant (cancerous) cells form within a kidney, usually in the lining of small tubes within the organ. While the condition affects both men and women and can occur at any age, kidney cancer tends to be seen more frequently in men who are 45 and older. There are two kidneys in the human body, located just above the waist on either side of the spine. Within each kidney are tiny tubes that function to filter waste products from the blood and produce urine. Malignant tumors that form within these tubes are known as renal cell carcinoma (RCC) and account for approximately 90 percent of all kidney cancer diagnoses.
Moffitt Cancer Center has distinguished itself as one of the nation’s premier cancer treatment facilities, and is the only facility based in Florida that has been named a Comprehensive Cancer Center by the National Cancer Institute. This prestigious designation recognizes our commitment to performing extensive research and conducting a robust clinical trial program, which allows us to offer kidney cancer treatments that are unavailable anywhere else.
At Moffitt Cancer Center, our multispecialty kidney cancer team includes:
- Board-certified physicians
- Radiation oncologists
- Other medical professionals
These specialists work closely together in our Urologic Oncology Program to provide outstanding patient care. For instance, we hold weekly collaborative tumor board discussions to assess each patient’s case and determine the best course of action to help the patient achieve the most active, enjoyable life possible. Our individualized treatment plans aim to minimize potential side effects, and if surgery is necessary, we use the most effective techniques and technologies available.
To learn more about kidney cancer and your treatment options, contact Moffitt Cancer Center at 1-888-663-3488, or use our online new patient registration form to schedule a visit. You do not need a referral to meet with our kidney cancer team. Some screening options may be available for high-risk patients.